Orchid Health
Article
Orchid Health is a recurring organization in the Astral Codex Ten archive, appearing 2 times across 2 issues between December 11, 2023 and July 31, 2025. The archive places it in contexts such as “Now new company Orchid Health wants me to mention that they are also offering this service”; “In 2023, Orchid Health entered the field”. It most often appears alongside 23andMe, 23andme, Aaron.
Metadata
- Category: Organizations
- Mention count: 2
- Issue count: 2
- First seen: December 11, 2023
- Last seen: July 31, 2025
Appears In
Related Pages
-
- 23andMe (1 shared issues)
-
- 23andme (1 shared issues)
-
- Aaron (1 shared issues)
-
- ACX Grants (1 shared issues)
-
- AI risk (1 shared issues)
-
- Alex Young (1 shared issues)
-
- angel investors (1 shared issues)
-
- anorexia (1 shared issues)
-
- Antagonistic Pleiotropy (1 shared issues)
-
- Astralcodexten Com (1 shared issues)
-
- autism (1 shared issues)
-
- Behavioral Genetics Society (1 shared issues)
External Links
Source Context
Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.
2: A few years ago I wrote about embryo screening, where people doing IVF with multiple embryos could determine which embryo had the healthiest genes and implant that one. That post focused on a the company called LifeView, mostly because they were the only ones offering the service at the time. Now new company Orchid Health wants me to mention that they are also offering this service. They claim to screen for more rare single-gene disorders than LifeView, as well as the usual polygenic screening for common problems like diabetes, obesity, and Alzheimers (although they may also be more expensive). Their Science and Clinician pages have more information, and their signup link is here.
In 2023, Orchid Health entered the field. Unlike Genomic Prediction, which tested only the most important genetic variants, Orchid offers whole genome sequencing, which can detect the de novo3 mutations involved in autism, developmental disorders, and certain other genetic diseases.
Inline links: Orchid Health, 3